Changes in cell junctions induced by inhibition of epidermal growth factor receptor in oral squamous cell carcinoma cells

The benefits of epidermal growth factor receptor (EGFR) targeting in the treatment of head and neck cancer, have been documented. However, a minority of patients with head and neck cancer are unresponsive to EGFR targeting therapies. The present study evaluated the effects and limitations of an EGFR...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakei, Yasumasa, Teraoka, Shun, Akashi, Masaya, Hasegawa, Takumi, Komori, Takahide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525654/
https://www.ncbi.nlm.nih.gov/pubmed/28810546
http://dx.doi.org/10.3892/etm.2017.4606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525654/
https://www.ncbi.nlm.nih.gov/pubmed/28810546
http://dx.doi.org/10.3892/etm.2017.4606

Ejemplares similares